VANCOUVER, BC, April 12, 2024 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA) declares that it has made an software to the British Columbia Securities Commission to approve a administration stop commerce order (“MCTO”) beneath National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203”), which, if granted, will prohibit the Chief Executive Officer and Chief Financial Officer of the Company from buying and selling in securities of the Company till such time because the Required Filings (outlined under) and all steady disclosure necessities have been filed by the Company and the MCTO has been revoked. During the interval wherein the MCTO is efficient, most people will proceed to have the ability to commerce within the Company’s listed securities. The MCTO software has been made however there is no such thing as a assure or assurance that the MCTO will likely be granted.

The Company expects that will probably be unable to file its audited annual consolidated monetary statements for the monetary 12 months ended December 31, 2023 (the “Financial Statements”) and the associated administration’s dialogue and evaluation and CEO and CFO certificates for a similar interval (collectively, with the Financial Statements, the “Required Filings”) earlier than the submitting deadline of April 29, 2024 (the “Filing Deadline”).

The Company’s incapacity to make the Required Filings by the Filing Deadline is because of delays within the Company’s skill to pay the excellent invoices and retainer of its auditors (the “Auditors”).  The Company is at the moment within the strategy of negotiating debt or fairness financing in an quantity enough to settle the quantities payable the Auditors. The Company anticipates that will probably be able to treatment the default by making the Required Filings on or earlier than June 29, 2024. The MCTO, if granted, will likely be in impact till the Required Filings are made.

Story continues

The Company will observe the choice info pointers set out in Sections 9 and 10 of NP 12-203 so long as the Required Filings are excellent.

About PanGenomic Health

PanGenomic Health is a precision well being firm that has developed a self-care digital platform to ship customized, evidence-based details about pure therapies. The Company’s preliminary focus is to assist psychological well being. Registered as a British Columbia profit firm, PanGenomic Health’s mission is to advertise and enhance the well being and wellness of individuals and society by offering a expertise platform that identifies plant-based options tailor-made to the well being profile of every particular person.

This information launch contains sure statements which may be deemed “forward-looking statements”, together with statements respecting the providers to be offered by PanGenomic Health and the consideration to be paid to PanGenomic Health. The use of any of the phrases “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and related expressions are meant to establish ahead trying statements. Although PanGenomic Health believes that the expectations and assumptions on which the forward-looking statements are primarily based are affordable, undue reliance shouldn’t be positioned on the forward-looking statements as a result of PanGenomic Health can provide no assurance that they are going to show to be appropriate. Since forward-looking statements tackle future occasions and situations, by their very nature they contain inherent dangers and uncertainties. These statements communicate solely as of the date of this News Release. Actual outcomes might differ materially from these at the moment anticipated because of a lot of elements and dangers together with varied threat elements mentioned in PanGenomic Health’s disclosure paperwork which will be discovered beneath PanGenomic Health’s profile on www.sedarplus.ca.

The Canadian Securities Exchange has neither authorised nor disapproved the knowledge contained herein and doesn’t settle for accountability for the adequacy or accuracy of this information launch.

SOURCE PanGenomic Health Inc.

View unique content material to obtain multimedia: http://www.newswire.ca/en/releases/archive/April2024/12/c7203.html